Pfizer/BioNTech has initiated its application to the US Food and Drug Administration for full FDA approval of its Covid-19 vaccine for people ages 16 and older, the companies said Friday. This is the ...

Company voluntarily withdraws IXCHIQ BLA and IND in the U.S. Continuing review of global product opportunity according to medical need and commercial attractivenessSaint Herblain (France), January 19, ...

Valneva has made the decision to withdraw the Biologics License Application for its chikungunya vaccine Ixchiq®.